Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse

A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination gen

Advancing Circulating Tumor DNA for Recurrent Breast Cancer

Reply to Di Cosimo et al.: Advancing circulating tumor DNA for recurrent breast cancer

Treatment response monitoring using a tumor-informed circulating tumor DNA test in an advanced triple negative breast cancer patient: A case

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

Magbanua et al. 2021 NPJ Breast Cancer

Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival

Magbanua et al. 2020 Annals of Oncology

Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence

Coombes et al. 2019 Clin. Cancer Res.

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients Wi

Christensen et al. 2019 J. Clin. Oncol.

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder

Molecular Residual Disease and Efficacy of Adjuvant Chemotherapy in Patients with Colorectal Cancer

Post-operative ctDNA monitoring in stage I colon cancer: A case report

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair d

DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy

Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer

Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Effic

A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca

Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of

Loupakis et al. 2021 JCO-PO

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in metastatic microsatellite stable colo...

Schneider et al. 2021 Case reports in Onc.